ORCA
Online Research @ Cardiff

Clear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 37.

Evangelou, Nikos, Garjani, Afagh, dasNair, Roshan, Hunter, Rachael, Tuite-Dalton, Katherine A, Craig, Elaine M, Rodgers, William J, Coles, Alasdair, Dobson, Ruth, Duddy, Martin, Ford, David Vincent, Hughes, Stella, Pearson, Owen, Middleton, Linda A, Rog, David, Tallantyre, Emma Clare, Friede, Tim, Middleton, Rodden M and Nicholas, Richard 2021. Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register. Journal of Neurology, Neurosurgery and Psychiatry 92 , pp. 107-109. 10.1136/jnnp-2020-324449

Hares, Kelly, Kemp, K., Loveless, S., Rice, C. M., Scolding, N., Tallantyre, E., Robertson, N. and Wilkins, A. 2021. KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis. Journal of Neurology 10.1007/s00415-020-10373-w

Winter, Mia, Tallantyre, Emma C., Brice, Thomas A. W., Robertson, Neil P., Jones, Derek K. and Chamberland, Maxime 2021. Tract-specific MRI measures explain learning and recall differences in multiple sclerosis. Brain Communications
Item availability restricted.

Zelek, Wioleta Milena, Fathalla, Dina, Morgan, Angharad, Touchard, Samuel, Loveless, Samantha, Tallantyre, Emma, Robertson, Neil P. and Morgan, B. Paul 2020. Cerebrospinal fluid complement system biomarkers in demyelinating disease. Multiple Sclerosis 26 (14) , pp. 1929-1937. 10.1177/1352458519887905

Tallantyre, Emma, Evans, Nia, Parry-Jones, Jack, Morgan, Matt, Jones, Ceri and Ingram, Wendy 2020. Neurological updates: neurological complications of CAR-T therapy. Journal of Neurology 10.1007/s00415-020-10237-3
Item availability restricted.

Anderson, Valerie, Bentley, Emily, Loveless, Sam, Bianchi, Lucia, Harding, Katharine E., Wynford-Thomas, Ray A., Joseph, Fady, Giovannoni, Gavin, Gnanapavan, Sharmilee, Robertson, Neil P., Marta, Monica and Tallantyre, Emma C. 2020. Serum neurofilament-light concentration and real-world outcome in MS. Journal of the Neurological Sciences 417 , 117079. 10.1016/j.jns.2020.117079

Item availability restricted.

Ontaneda, Daniel, Tallantyre, Emma C., Raza, Praneeta C., Planchon, Sarah M., Nakamura, Kunio, Miller, Deborah, Hersh, Carrie, Craner, Mathew, Bale, Clare, Chaudhry, Burhan, Gunzler, Douglas D., Love, Thomas E., Gerry, Stephen, Coles, Alasdair, Cohen, Jeffrey A. and Evangelou, Nikos 2020. Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol. Contemporary Clinical Trials 95 10.1016/j.cct.2020.106009
Item availability restricted.

Saxena, Gauri, Moore, James, Jones, Meleri, Pryce, Gareth, Ali, Liaqat, Leisegang, Georgia, Vijay, Vivek, Loveless, Samantha, Robertson, Neil, Schmierer, Klaus, Giovannoni, Gavin, Gnananpavan, Sharmilee, Baker, David, Tallantyre, Emma and Kang, Angray 2020. Detecting and predicting neutralization of alemtuzumab responses in multiple sclerosis. Neurology, Neuroimmunology and Neuroinflammation 7 (4) , e767. 10.1212/NXI.0000000000000767

Tallantyre, Emma, Castle, Daniel, Karamura, Paul, Brice, Thomas, Joseph, Fady, Harding, Katharine and Robertson, Neil 2020. Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort. Multiple Sclerosis and Related Disorders 42 , 102056. 10.1016/j.msard.2020.102056
Item availability restricted.

Tallantyre, Emma, DPhil, Nikos, Chaudhry, Burham, Gray, Emma, LaRocca, Nicolas, Pavitt, Sue, Millar, Deborah, Planchon, Sarah, Ontaneda, Daniel and Manzano, Ana 2020. Achieving effective patient and public involvement in international clinical trials in neurology. Neurology 10 (3) , pp. 265-272. 10.1212/CPJ.0000000000000739

Saxena, Gauri, Moore, James M., Jones, Meleri, Pryce, Gareth, Ali, Liaqat, Leisegang, Georgia R., Vijay, Vivek, Loveless, Samantha, Robertson, Neil P., Schmierer, Klaus, Giovannoni, Gavin, Gnananpavan, Sharmilee, Baker, David, Tallantyre, Emma C. and Kang, Angray S. 2020. Detecting and predicting neutralization of alemtuzumab responses in MS. Neurology, Neuroimmunology and Neuroinflammation 7 (4) , e767. 10.1212/NXI.0000000000000767

Lipp, Ilona, Parker, Greg D., Tallantyre, Emma C., Goodall, Alex, Grama, Steluta, Patitucci, Eleonora, Heveron, Phoebe, Tomassini, Valentina and Jones, Derek K. 2020. Tractography in the presence of multiple sclerosis lesions. NeuroImage 209 , 116471. 10.1016/j.neuroimage.2019.116471

Allen, Christopher M., Feng, Jenny J., Willis, Mark D., McGinley, Marisa, Ontaneda, Daniel, Tallantyre, Emma C. and Evangelou, Nikos 2020. Clinical observation during alemtuzumab administration. Multiple Sclerosis and Related Disorders 37 , 101412. 10.1016/j.msard.2019.101412

Chamberland, Maxime, Winter, Mia, Brice, Thomas A. W., Jones, Derek K. and Tallantyre, Emma C. 2020. Beyond lesion-load: tractometry-based metrics for characterizing white matter lesions within ﬁbre pathways. Presented at: MICCAI 2020 International Workshop on Computational Diffusion MRI (CDMRI 2020), Virtual, 8 October 2020.

Lipp, Ilona, Foster, Catherine, Stickland, Rachael, Sgarlata, Eleonora, Tallantyre, Emma C., Davidson, Alison E., Robertson, Neil P., Jones, Derek K., Wise, Richard G. and Tomassini, Valentina 2020. Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: a behavioural and MRI study. Multiple Sclerosis 10.1177/1352458520943788

Davda, Nikunj, Tallantyre, Emma and Robertson, Neil P. 2019. Early MRI predictors of prognosis in multiple sclerosis. Journal of Neurology 266 (12) , pp. 3171-3173. 10.1007/s00415-019-09589-2

Ontaneda, Daniel, Tallantyre, Emma, Kalincik, Tomas, Planchon, Sarah M and Evangelou, Nikos 2019. Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis. Lancet Neurology 18 (10) , pp. 973-980. 10.1016/S1474-4422(19)30151-6

Abdullah, Ali Adel Ne'ma and Tallantyre, Emma 2019. HSV-2 radiculitis: An unusual presentation mere days after genital infection. Clinical Neurology and Neurosurgery 185 , 105429. 10.1016/j.clineuro.2019.105429

Castle, Daniel, Wynford-Thomas, Ray, Loveless, Sam, Bentley, Emily, Howell, Owain W and Tallantyre, Emma C 2019. Using biomarkers to predict clinical outcomes in multiple sclerosis. Practical Neurology 19 (4) , pp. 342-349. 10.1136/practneurol-2018-002000

Lipp, Ilona, Jones, Derek K., Bells, Sonya, Sgarlata, Eleonora, Foster, Catherine, Stickland, Rachael, Davidson, Alison E., Tallantyre, Emma C., Robertson, Neil P., Wise, Richard C. and Tomassini, Valentina 2019. Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis. Human Brain Mapping 40 (10) , pp. 2917-2932. 10.1002/hbm.24568

Harding, Katharine, Williams, Owain, Willis, Mark, Hrastelj, James, Rimmer, Anthony, Joseph, Fady, Tomassini, Valentina, Wardle, Mark, Pickersgill, Trevor, Robertson, Neil and Tallantyre, Emma 2019. Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis. JAMA Neurology 76 (5) , pp. 536-541. 10.1001/jamaneurol.2018.4905

Whittam, Daniel H, Tallantyre, Emma C, Jolles, Stephen, Huda, Saif, Moots, Robert J, Kim, Ho Jin, Robertson, Neil P, Cree, Bruce A C and Jacob, Anu 2019. Rituximab in neurological disease: principles, evidence and practice. Practical Neurology 19 (1) , pp. 5-10. 10.1136/practneurol-2018-001899

Tallantyre, Emma C., Robertson, Neil P. and Jolles, Stephen 2018. Secondary antibody deficiency in neurology. Current Opinion in Allergy and Clinical Immunology 18 (6) , pp. 481-488. 10.1097/ACI.0000000000000485

Robertson, JA and Tallantyre, EC 2018. Nerve sheath tumours. Journal of Neurology 265 (12) , pp. 3034-3035. 10.1007/s00415-018-9098-y

Beesley, Rebecca, Anderson, Valerie, Harding, Katharine E, Joseph, Fady, Tomassini, Valentina, Pickersgill, Trevor P, Robertson, Neil P and Tallantyre, Emma C 2018. Impact of the 2017 revisions to McDonald criteria on the diagnosis of Multiple Sclerosis. Multiple Sclerosis 24 (13) , pp. 1786-1787. 10.1177/1352458518778007

Harding, Katharine, Anderson, Valerie, Williams, Owain, Willis, Mark, Butterworth, Sara, Tallantyre, Emma, Joseph, Fady, Wardle, Mark, Pickersgill, Trevor and Robertson, Neil 2018. A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple Sclerosis and Related Disorders 25 , pp. 186-191. 10.1016/j.msard.2018.08.001

Tallantyre, Emma Clare, Major, Paula C., Atherton, Michael J., Davies, W. Adam, Joseph, Fady, Tomassini, Valentina, Pickersgill, Trevor P., Harding, Katharine E., Willis, Mark Douglas, Winter, Mia and Robertson, Neil P. 2018. How common is truly benign MS in a UK population? Journal of Neurology, Neurosurgery and Psychiatry 90 , pp. 522-528. 10.1136/jnnp-2018-318802

Alsaeed, Meshari, Harding, Katharine, Williams, O. H., Willis, Mark, Hrastelj, James, Tallantyre, Emma, Joseph, Fady, Wardle, Mark, Pickersgill, T. P. and Robertson, Neil 2018. Multiple sclerosis: long-term outcomes in ethnic minorities. analysis of a UK population-based registry. European Journal of Neurology 25 (4) , pp. 701-704. 10.1111/ene.13571

Tallantyre, Emma, Whittam, D. H., Jolles, Stephen, Paling, D., Constantinescu, C., Robertson, Neil and Jacob, A. 2018. Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. Journal of Neurology 265 (5) , pp. 1115-1122. 10.1007/s00415-018-8812-0

Willis, Mark, Pearson, Owen, Illes, Zsolt, Sejbaek, Tobias, Nielson, Christian, Duddy, Martin, Petheram, Kate, van Munster, Casper, Killestein, Joep, Malmestrom, Clas, Tallantyre, Emma and Robertson, Neil 2017. An observational study of alemtuzumab following fingolimod for multiple sclerosis. Neuroimmunology and Neuroinflammation 4 (2) , E320. 10.1212/NXI.0000000000000320

Tallantyre, Emma C. and Robertson, Neil Patrick 2016. Continuous evolution of magnetic resonance imaging in multiple sclerosis. Journal of Neurology 263 (4) , pp. 835-837. 10.1007/s00415-016-8099-y

Tallantyre, Emma C., Wardle, Mark and Robertson, Neil 2016. How to run a multiple sclerosis relapse clinic. Practical Neurology 16 (1) , pp. 62-69. 10.1136/practneurol-2015-001214

Thomas, Rhys Huw, Devine, Helen, Donnelly, Ann, Foulkes, Alexander, Galtrey, Clare, Khaleeli, Zhaleh, Lawrence, Joanne, Novak, Marianne, Redgrave, Jessica and Tallantyre, Emma C. 2015. Why neurology? The career choices of current UK neurology trainees [Conference Abstract]. Journal of Neurology, Neurosurgery & Psychiatry 86 (11) , e4. 10.1136/jnnp-2015-312379.42

Williams, Owain, Tallantyre, Emma C. and Robertson, Neil 2015. Traumatic brain injury: pathophysiology, clinical outcome and treatment. Journal of Neurology 262 (5) , pp. 1394-1396. 10.1007/s00415-015-7741-4

Tallantyre, Emma, Causon, E. G., Harding, Katharine, Pickersgill, T. P. and Robertson, Neil 2015. The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic. Multiple Sclerosis Journal 21 (1) , pp. 67-75. 10.1177/1352458514538333

Tallantyre, Emma C. and Robertson, Neil 2015. Acute stroke management. Journal of Neurology 262 (1) , pp. 239-242. 10.1007/s00415-014-7607-1

Tallantyre, Emma C. and Robertson, Neil 2013. Autism and intellectual disability. Journal of Neurology 260 (3) , pp. 936-939. 10.1007/s00415-013-6861-y

This list was generated on Sun Mar 7 03:55:04 2021 GMT.

Export as	Atom RSS 1.0 RSS 2.0